Patent linkage system serves as a crucial tool in the pharmaceutical industry, strategically aligning the approval process of generic drugs with the patent status of
The final versions of the updated Guidelines for Patent Examination and the Implementing Rules for the Patent Law were released by the China National Intellectual
Patent is a type of intellectual property right that provides protection over novel inventions and, gives the innovator an exclusive right to sell, use, create
Generics for Otezla® to be out in the United States in February 2028 Amgen’s oral phosphodiesterase-4 (PDE-4) inhibitor – Otezla® (Apremilast) is approved in the
